Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update

O'Brien, Daniel P, Jenkin, Grant, Buntine, John, Steffen, Christina M, McDonald, Anthony, Horne, Simon, Friedman, N Deborah, Athan, Eugene, Hughes, Andrew, Callan, Peter P and Johnson, Paul D R 2014, Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update, Medical journal of Australia, vol. 200, no. 5, pp. 267-270, doi: 10.5694/mja13.11331.

Attached Files
Name Description MIMEType Size Downloads

Title Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update
Formatted title Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update
Author(s) O'Brien, Daniel P
Jenkin, Grant
Buntine, John
Steffen, Christina M
McDonald, Anthony
Horne, Simon
Friedman, N Deborah
Athan, EugeneORCID iD for Athan, Eugene orcid.org/0000-0001-9838-6471
Hughes, Andrew
Callan, Peter P
Johnson, Paul D R
Journal name Medical journal of Australia
Volume number 200
Issue number 5
Start page 267
End page 270
Total pages 4
Publisher AMPCo
Place of publication Strawberry Hills, N.S.W.
Publication date 2014-03-17
ISSN 0025-729X
1326-5377
Keyword(s) anti-bacterial agents
Australia
Buruli ulcer
debridement
drug therapy, combination
hot temperature
humans
Mycobacterium ulcerans
practice guidelines as topic
rifampin
streptomycin
Summary • Guidelines reflecting contemporary clinical practice in the management of Buruli ulcer (Mycobacterium ulcerans infection) in Australia were published in 2007.

• Management has continued to evolve, as new evidence has become available from randomised trials, case series and increasing clinical experience with oral antibiotic therapy.

• Therefore, guidelines on the diagnosis, treatment and prevention of Buruli ulcer in Australia have been updated. They include guidance on the new role of antibiotics as first-line therapy; the shortened duration of antibiotic treatment and the use of all-oral antibiotic regimens; the continued importance, timing and role of surgery; the recognition and management of paradoxical reactions during antibiotic treatment; and updates on the prevention of disease.
Language eng
DOI 10.5694/mja13.11331
Field of Research 111799 Public Health and Health Services not elsewhere classified
1117 Public Health And Health Services
1103 Clinical Sciences
Socio Economic Objective 920499 Public Health (excl. Specific Population Health) not elsewhere classified
HERDC Research category C2.1 Other contribution to refereed journal
Copyright notice ©2014, AMPCo
Persistent URL http://hdl.handle.net/10536/DRO/DU:30086596

Document type: Journal Article
Collections: School of Medicine
Deposit Agreements needed
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 17 times in TR Web of Science
Scopus Citation Count Cited 20 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 58 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Mon, 10 Oct 2016, 09:29:32 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.